William L. Macias

Insider Reports History

Location
New York, NY
Signature
/s/ Eva Renee Barnett, attorney-in-fact for William L. Macias
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William L. Macias:

Form 4 holding Chief Medical Officer

Immunovant, Inc.

Security class
Common Stock
Shares / value
357,353
Estimated value
$7,454,384
Report date
19 Feb 2025
Price
$20.86
Ownership
Direct
Form 4 holding Chief Medical Officer

Immunovant, Inc.

Security class
Stock Option (right to buy)
Shares / value
68,723
Estimated value
Report date
02 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by William L. Macias

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .